Manchester institute of Biotechnology (MIB) which was founded in 2006 as the UK’s first university-based purpose-built interdisciplinary bioscience research institute. Renamed in 2012, the MIB (based at the University of Manchester) is now a world leading biotechnology research institute with state-of-the-art facilities and a beacon of interdisciplinary and industry-interfaced bioscience that is driving bio-based chemicals synthesis.
MIB’s cross-disciplinary research aims to develop new biotechnologies that have applications in human health, the energy economy, food security and the environment. Supported by a funding portfolio of ca £70M, MIB research is helping to drive the UK’s strategic development of biomanufacturing, specifically in areas of pharmaceuticals, value-added chemicals, advanced materials, and next-generation biofuels.
The University of Manchester (UoM) is one of the largest single-site universities in the UK, with one of the biggest student communities. Recognized as a global powerhouse of research with 93% of the University’s research activity assessed as ‘world-leading’ or ‘internationally excellent’ in the Research Excellence Framework (REF) 2021. UoM ranked 38th in the world in the 2021 Academic Ranking of World Universities and 12th in Europe in 2019 Reuters Top 100 Most Innovative Universities.